Most longevity research was conducted on men. These guides address the biology, hormones, and aging patterns unique to women — with evidence-based protocols for every stage of life.
Female biology introduces unique longevity challenges — and unique opportunities. These are the three biggest reasons women need their own evidence-based roadmap.
Women experience a sharp, accelerated aging event that men don't — the menopausal transition. Estrogen loss drives rapid bone density decline, cardiovascular risk escalation, and metabolic changes in a compressed timeframe. The window for intervention is narrow and specific.
Until the 1990s, most clinical trials excluded women. Even today, many longevity protocols are derived from male-predominant data. Women metabolize supplements differently, respond to exercise differently, and face different disease risk profiles — demanding female-specific evidence review.
No other area of longevity medicine involves as much nuance as HRT for women. Timing, formulation, delivery method, and individual risk factors all matter enormously — and the evidence has shifted dramatically in the last decade. Women need clear, unbiased decision frameworks.
Each guide is grounded in peer-reviewed research, includes practical protocols, and is written for real decision-making — not vague advice.
What actually happens during the 5–10 year transition before menopause — the symptoms, the biomarker shifts, and the evidence-based interventions to protect your healthspan during the most dynamic hormonal period of your life.
An interactive, evidence-based tool to help you evaluate whether hormone replacement therapy is appropriate for your situation. Walk through risk factors, timing, formulation options, and the latest research — then generate a personalized summary for your doctor.
Which hormones, metabolic markers, and bone density indicators to test — and when. Includes optimal ranges for peri- and post-menopausal women, testing frequency recommendations, and how to interpret trending values over time.
Women lose up to 20% of bone density in the 5–7 years after menopause. This guide covers the evidence for exercise loading patterns, nutrition, supplements, medications, and the specific DEXA targets that correlate with fracture prevention.
How training should differ for women — cycle-synced periodization, the critical role of resistance training for bone and metabolic health, menopause-adapted cardio programming, and the evidence behind Zone 2, HIIT, and plyometric loading for female bodies.
These deep-dive articles complement the guides above — providing additional context, evidence reviews, and condition-specific protocols.
Not sure which guide to read first? Here's the path we'd suggest depending on where you are in life.
Start with the Perimenopause Guide to understand the hormonal shifts ahead — even if you're years away.
Perimenopause Guide →Use the Biomarker Tracking Guide to build your testing plan and understand your baseline.
Biomarker Guide →Read the Exercise Protocol to build a training plan that matches your hormonal stage.
Exercise Protocol →Estimate your biological age with inputs including hormonal and metabolic markers.
Build a testing plan with female-specific biomarkers and optimal ranges.
Upload your bloodwork and see where you stand versus longevity-optimal targets.
Verify your supplement stack for interactions — including HRT interactions.